Holoclara is dedicated to developing innovative therapies aimed at alleviating the suffering of individuals with debilitating diseases through the use of worms. Their approach leverages the unique properties of these organisms, particularly focusing on the therapeutic effects that their secretions and excretions have on the mammalian immune system. This strategy is grounded in scientific research that highlights the anti-inflammatory effects of these substances across various immune cell types, suggesting a potential pathway for treatment.

The company's scientific efforts are concentrated on identifying and mapping the specific molecules secreted by therapeutic worm species. By analyzing the individual effects of these molecules on a wide array of immune cells, Holoclara aims to understand how they can modulate immune responses that are implicated in allergic and autoimmune diseases. This research not only underscores the potential of worm-derived therapies but also positions Holoclara at the forefront of a novel approach to immunotherapy.

United States

Holoclara is a startup focused on worm-derived therapies for allergic and autoimmune disease. The company aims to bring relief to people suffering from autoimmune disorders through the delivery of nematode-derived molecules.

Holoclara

Company Details